Relevance of reversible inhibitors of monoamine oxidase type A and of reuptake inhibition for noradrenaline turnover
| Autor: | Roman Amrein, D. Hartmann, A. M. Cesura, W. Schmid-Burgk |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
medicine.medical_specialty
Cytoplasm Monoamine Oxidase Inhibitors Moclobemide Reuptake Norepinephrine Desipramine Internal medicine Monoaminergic medicine Animals Humans Neurons Depressive Disorder Chemistry Brain Psychiatry and Mental health Kinetics Monoamine neurotransmitter Endocrinology Benzamides Antidepressant Serotonin Synaptic Vesicles Reuptake inhibitor medicine.drug |
| Zdroj: | Acta psychiatrica Scandinavica. Supplementum. 386 |
| ISSN: | 0065-1591 |
| Popis: | Noradrenaline (NA) and serotonin, monoamines that increase neurotransmission at the monoaminergic synapses, remain primary targets for antidepressant drugs. To help elucidate NA's role in the action of antidepressants, a model was set up allowing for a simulation of NA turnover under various conditions examining 3 compartments: newly synthesized vesicular NA, released synaptic NA, and vesicular NA reuptake across neuronal membranes. We compared the influence of the reversible MAO inhibitor, moclobemide, and the NA reuplake inhibitor, desipramine, both useful in regaining baseline synaptic NA concentrations. Moclobemide appears less sensitive to fluctuations either in drug concentrations and/or physiological determinants of NA turnover; we conclude that it may influence brain function in a more regulatory way than reuptake inhibitors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|